Abstract
The in vivo and in vitro pharmacokinetics of mercury (Hg) were compared between methylmercury chloride (MeHg·Cl) and methylmercury cysteine (MeHg-Cys) using rats and Caco2 cells because humans can be exposed to MeHg compounds through dietary fish. The in vivo pharmacokinetics of Hg immediately after the digestion of MeHg compounds are still obscure. In Caco2 cells, membrane uptake and subcellular distribution of MeHg compounds were examined. When rats received it intravenously, MeHg·Cl showed 20-fold greater plasma and 2-fold greater blood concentrations of Hg than MeHg-Cys, indicating that their pharmacokinetic properties are different. One hour later, however, Hg concentrations in plasma and blood became virtually identical between MeHg·Cl and MeHg-Cys, although blood Hg concentrations were >100-fold greater than those in plasma. When administered into the closed rat’s jejunum loop, MeHg·Cl and MeHg-Cys were rapidly and efficiently taken up by intestinal membranes, and Hg was retained in intestinal membranes for a relatively long time. When administered orally, no difference was observed in plasma and blood Hg concentrations between MeHg·Cl and MeHg-Cys: plasma and blood Hg concentrations increased gradually and reached steady levels at 8 h after administration. In Caco2 cells, uptake of MeHg-Cys was significantly suppressed by l-leucine, although this was not seen with MeHg·Cl. In Caco2 cells, 81 % of Hg was recovered from cytosol fractions and 13 % of Hg from nuclear fractions (including debris) after a 2-h incubation with MeHg-Cys. In conclusion, the mechanism of membrane uptake and volume of distribution in the initial distribution phase were clearly different between MeHg·Cl and MeHg-Cys. However, such pharmacokinetic differences between them disappeared 1 h after intravenous and after oral routes of administration, possibly due to the metabolism in the body.
Similar content being viewed by others
References
Aberg B, Ekman L, Falk R, Greitz U, Persson G, Snihs J-O (1969) Metabolism of methyl mercury (203Hg) compounds in man. Excretion and distribution. Arch Environ Health 19:478–484
Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880–885
Ballatori N (2002) Transport of toxic metals by molecular mimicry. Environ Health Perspect 110(Suppl 5):689–694
Berglund M, Lind B, Björnberg KA, Palm B, Einarsson O, Vahter M (2005) Inter-individual variations of human mercury exposure biomarkers: a cross-sectional assessment. Environ Health 4:20
Björkman L, Lundekvam BF, Laegreid T, Bertelsen BI, Morild I, Lilleng P et al (2007) Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health 6:30
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bridges CC, Zalups RK (2010) Transport of inorganic mercury and methylmercury in target tissues and organs. J Toxicol Environ Health B 13:385–410
Canuel R, de Grosbois SB, Atikessé L, Lucotte M, Arp P, Ritchie C et al (2006) New evidence on variations of human body burden of methylmercury from fish consumption. Environ Health Perspect 114:302–306
Clarkson TW (2002) The three modern faces of mercury. Environ Health Perspect 110:11–23
Clarkson TW, Vyas JB, Ballatori N (2007) Mechanisms of mercury disposition in the body. Am J Ind Med 50:757–764
Díez S (2009) Human health effects of methylmercury exposure. Rev Environ Contam Toxicol 198:111–132
Farina M, Aschner M, Rocha JBT (2011) Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol 256:405–417
Fraga S, Serrão MP, Soares-da-Silva P (2002) L-Type amino acid transporters in two intestinal epithelial cell lines function as exchangers with neutral amino acids. J Nutr 132:733–738
George GN, Singh SP, Prince RC, Pickering IJ (2008) Chemical forms of mercury and selenium in fish following digestion with simulated gastric fluid. Chem Res Toxicol 21:2106–2110
Grasset E, Pinto M, Dassauix E, Zweibaum A, Desjeux JF (1984) Epithelial properties of human colonic carcinoma cell line Caco-2 electrical parameters. Am J Physiol 247:C260–C267
Greener Y, Kochen JA (1983) In vitro studies on methyl mercury distribution in human blood. Teratology 28:375–387
Harris HH, Pickering IJ, George GN (2003) The chemical form of mercury in fish. Science 301:1203
Heggland I, Kaur P, Syversen T (2009) Uptake and efflux of methylmercury in vitro: comparison of transport mechanisms in C6, B35 and RBE4 cells. Toxicol In Vitro 23:1020–1027
Hunter J, Hirst BH, Simmons NL (1993) Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm Res 10:743–749
Ishihara N (2000) Excretion of methyl mercury in human feces. Arch Environ Health 55:44–47
Jacobs MB, Yamaguchi S, Goldwater LJ, Gilbert H (1960) Determination of mercury in blood. Am Ind Hyg Assoc J 21:475–480
Kanai Y, Endou H (2003) Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. J Toxicol Sci 28:1–17
Kerper LE, Ballatori N, Clarkson TW (1992) Methylmercury transport across the blood–brain barrier by an amino acid carrier. Am J Physiol 262:R761–R765
Kershaw TG, Clarkson TW, Dhahir PH (1980) The relationship between blood levels and dose of methylmercury in man. Arch Environ Health 35:28–36
Michihara A, Akasaka K, Yamoru Y, Tsuji H (2003) Subcellular distribution of mouse mevalonate pyrophosphate dicarboxylase. Biol Pharm Bull 26:579–584
Roos DH, Puntel RL, Lugokenski TH, Ineu RP, Bohrer D et al (2010) Complex methylmercury-cysteine alters mercury accumulation in different tissues of mice. Basic Clin Pharmacol Toxicol 107:789–792
Rosenberg R (1982) Na-independent and Na-dependent transport of neutral amino acids in the human red blood cell. Acta Physiol Scand 116:321–330
Sällsten G, Barregård L, Schütz A (1993) Decrease in mercury concentration in blood after long term exposure: a kinetic study of chloralkali workers. Br J Ind Med 50:814–821
Sällsten G, Barregård L, Schütz A (1994) Clearance half life of mercury in urine after the cessation of long term occupational exposure: influence of a chelating agent (DMPS) on excretion of mercury in urine. Occup Environ Med 51:337–342
Simmons-Willis TA, Koh AS, Clarkson TW, Ballatori N (2002) Transport of a neurotoxicant by molecular mimicry: the methylmercury-l-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem J 367:239–246
Simpson RB (1961) Association constant of methylmercury with sulfhydryl and other bases. J Am Chem Soc 83:4711–4717
Smith JC, Farris FF (1996) Methyl mercury pharmacokinetics in man: a reevaluation. Toxicol Appl Pharmacol 137:245–252
Smith JC, Allen PV, Turner MD, Most B, Fisher HL, Hall LL (1994) The kinetics of intravenously administered methyl mercury in man. Toxicol Appl Pharmacol 128:251–256
Storelli MM, Barone G, Piscitelli G, Marcotrigiano GO (2007) Mercury in fish: concentration vs. fish size and estimates of mercury intake. Food Addit Contam 24:1353–1357
Sundberg J, Ersson B, Lönnerdal B, Oskarsson A (1999) Protein binding of mercury in milk and plasma from mice and man—a comparison between methylmercury and inorganic mercury. Toxicology 137:169–184
Thomas DJ, Fisher HL, Sumler MR, Mushak P, Hall LL (1987) Sexual differences in the excretion of organic and inorganic mercury by methyl mercury-treated rats. Environ Res 43:203–216
Thomas DJ, Fisher HL, Sumler MR, Hall LL, Mushak P (1988) Distribution and retention of organic and inorganic mercury in methyl mercury-treated neonatal rats. Environ Res 47:59–71
Urano T, Naganuma A, Imura N (1988) Methylmercury-cysteinylglycine constitutes the main form of methylmercury in rat bile. Res Commun Chem Pathol Pharmacol 60:197–210
Urano T, Iwasaki A, Himeno S, Naganuma A, Imura N (1990) Absorption of methylmercury compounds from rat intestine. Toxicol Lett 50:159–164
Usuki F, Takahashi N, Sasagawa N, Ishiura S (2000) Differential signaling pathways following oxidative stress in mutant myotonin protein kinase cDNA-transfected C2C12 cell lines. Biochem Biophys Res Commun 267:739–743
Wils P, Phung-Ba V, Warnery A, Lechadeur D, Raeissi S et al (1994) Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol 48:1528–1530
World Health Organization (2008) Guidance for identifying populations at risk from mercury exposure. WHO, Geneva. http://www.chem.unep.ch/mercury/IdentifyingPopnatRiskExposuretoMercuryFinalAugust08.pdf
World Health Organization (2010) Children’s exposure to mercury compounds. WHO, Geneva. http://whqlibdoc.who.int/publications/2010/9789241500456_eng.pdf
Yamamoto M (1995) Possible mechanism of elemental mercury oxidation in the presence of SH compounds in aqueous solution. Chemosphere 31:2791–2798
Yamamoto M, Charoenraks T, Pan-Hou H, Nakano A, Apilux A, Tabata M (2007) Electrochemical behaviors of sulfhydryl compounds in the presence of elemental mercury. Chemosphere 69:534–539
Yee S (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in human: fact or myth. Pharm Res 14:763–766
Young JD, Wolowyk MW, Jones SM, Ellory JC (1983) Red-cell amino acid transport. Evidence for the presence of system ASC in mature human red blood cells. Biochem J 216:349–357
Zalups RK (2000) Molecular interactions with mercury in the kidney. Pharmacol Rev 52:113–143
Zalups RK, Ahmad S (2005) Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1. Kidney Int 68:1684–1699
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mori, N., Yamamoto, M., Tsukada, E. et al. Comparison of In Vivo with In Vitro Pharmacokinetics of Mercury Between Methylmercury Chloride and Methylmercury Cysteine Using Rats and Caco2 Cells. Arch Environ Contam Toxicol 63, 628–636 (2012). https://doi.org/10.1007/s00244-012-9800-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00244-012-9800-5